ExploreWatchlistsPricing
  1. JP-listed companies
  2. Fuji Pharma Co.,Ltd.
  3. Financials
  4. Capital expenditures

Fuji Pharma Co.,Ltd. (4554)

Market cap
¥61.1B
P/E ratio
26.8x
Develops and manufactures specialized injectable medications for hospitals and medical distributors, focusing on hormone treatments and medical imaging contrast agents.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndCapital expenditures (Million JPY)YoY (%)
Sep 30, 2025-1,981-28.69%
Sep 30, 2024-2,778-16.50%
Sep 30, 2023-3,327-34.73%
Sep 30, 2022-5,097+34.52%
Sep 30, 2021-3,789+63.18%
Sep 30, 2020-2,322+36.51%
Sep 30, 2019-1,701+17.63%
Sep 30, 2018-1,446-2.10%
Sep 30, 2017-1,477-36.01%
Sep 30, 2016-2,308+52.65%
Sep 30, 2015-1,512+40.13%
Sep 30, 2014-1,079

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat